0
     

Report Added
Report already added
Medical Radiation Shielding Market by Products (Shields, Booths, Lead sheet, Doors, Windows, Curtain, X-Ray), Solution (Radiation Therapy, Cyclotron, PET, CT, MRI), End-user (Hospitals, Clinics, ASCs, Diagnostic Center), & Region - Global Forecast to 2028

Medical Radiation Shielding Market by Products (Shields, Booths, Lead sheet, Doors, Windows, Curtain, X-Ray), Solution (Radiation Therapy, Cyclotron, PET, CT, MRI), End-user (Hospitals, Clinics, ASCs, Diagnostic Center), & Region - Global Forecast to 2028

The medical radiation shielding market is projected to reach USD 1.8 Billion by 2028 from USD 1.4 Billion in 2023, at a CAGR of 6.5% during the forecast period. Growth in MRI shielding products is mainly driven by the Awareness of the potential health risks associated with exposure to ionizing radiation is increasing rapidly among people working in radiation-prone environments.

Various government and private organizations, such as Health Canada, the National Council on Radiation Protection & Measurements (NCRP), and the Australian Radiation Protection and Nuclear Safety Agency (ARPANSA), have incorporated guidelines and protocols regarding radiation shielding products. These initiatives increase safety awareness among professionals and encourage the adoption of radiation protection systems. Conferences and symposia also showcase research in this field and make industry leaders aware of the developments in this sector.

“The Diagnostic Shielding segment accounted for the highest market share in the medical radiation shielding solution market, by type, during the forecast period.”

Based on the solution of the segment, the medical radiation shielding market is categorized as Diagnostic Shielding and Radiation Therapy Shielding. Diagnostic Shielding is expected to have the highest growth in the market, which is attributed to the rising prevalence of various chronic diseases like cancer, which is attributed to the Increasing public-private investments in cancer research, id supporting the growth of the Diagnostic Shielding market.

“The North America segment accounted for the highest market share in the medical radiation shielding market, by region, during the forecast period.”

Based on the region, the global medical radiation shielding market is categorized into North America, Europe, Asia Pacific, and Rest of the world. North America is expected to witness a high market share during the forecast period due to the Increasing number of trained radiologic technologists. According to the Bureau of Labor Statistics, in 2020, ~254,000 radiologic technologists’ jobs were expected to be available in the US. The Bureau of Labor Statistics has also estimated that the employment of radiologic and MRI technologists is expected to grow at a rate of 9% from 2020 to 2030 in the US.

Breakdown of supply-side primary interviews by company type, designation, and region:
• By Company Type: Tier 1 (32%), Tier 2 (46%), and Tier 3 (22%)
• By Designation: C-level (40%), Director-level (26%), and Others (34%)
• By Region: North America (35%), Europe (30%), Asia- Pacific (21%), RoW- (14%),

Prominent companies include ESCO Technologies (US), Mirion Technology (US), Nelco Worldwide (US), Gaven Industries Inc. (US), Radiation Protection Products, Inc. (US), Marshield (Canada), Ray-Bar Engineering Corp. (US), Amray Medical (Ireland), A&L Shielding (US), Global Partners in Shielding Inc. (US), Veritas Medical Solutions LLC. (US), AliMed Inc. (US), Protech Medical (US), Ultraray (US), Mars Metal Company (Canada), Nuclear Lead Co. Inc. (US), Nuclear Shields B.V. (Netherlands), Globe Composite Solutions LLC. (US), Shielding International Inc. (US), Bar-Ray Products (US), Xena Shield (India), Burlington Medical (US), SIMAD S.r.l. (Italy) and European EMC Products (UK).

Research Coverage
This research report categorizes the medical radiation shielding market by product (MRI Shielding Products, Lead Lined Glass, Doors & Windows, Lead Lined Drywalls & Plywood, Shields, Barriers, Booths, Lead Sheet, Lead Bricks, High-Density Concrete Blocks, X-ray Rooms, Lead Curtains & Screens and Lead Acrylic), By Solution (Diagnostic Shielding and Radiation Therapy Shielding), Diagnostic Shielding segment (X-ray, MRI, CT scanners and Nuclear Imaging) and Radiation Therapy Shielding segment (Linear Accelerator, Multimodality, Cyclotron, Brachytherapy, and Proton Therapy), by end-user (Hospitals, Clinics and Ambulatory Surgery Centers and Diagnostic Centers), and region (North America, Europe, Asia Pacific and Rest of world).

The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of the medical radiation shielding market. A detailed analysis of the key industry players has been done to provide insights into their business overview, solutions, services; key strategies; Contracts, partnerships, and agreements. New product & service launches, mergers and acquisitions, and recent developments associated with the medical radiation shielding market. Competitive analysis of upcoming startups in the medical radiation shielding market ecosystem is covered in this report.

Key Benefits of Buying the Report:
The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall medical radiation shielding market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.

The report provides insights on the following pointers:
•Analysis of key drivers (Increasing usage of nuclear medicine and radiation therapy for diagnosis and treatment, Growing incidences of cancer, Increasing safety awareness among people working in radiation-prone environments, Growth in the number of PET/CT scans, and Increasing number of trained radiologic technologists,), restraints (Lack of adequate healthcare infrastructure and Dearth Of Skilled Oncologist/Radiologist) opportunities (Rising healthcare expenditure across developing countries, Increasing public-private investments in cancer research, Growing government and private investments to meet the increasing demand for cancer treatment, Technological advancements in radiation detection and Increasing usage of nuclear medicine & radiation therapy coupled with the rising incidence of cancer) and Challenges (High cost of lead in manufacturing radiation accessories) are influencing the growth of the radiation shielding market.
•Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the medical radiation shielding market.
•Market Development: Comprehensive information about lucrative markets – the report analyses the medical radiation shielding market across varied regions.
•Market Diversification: Exhaustive information about new products & services, untapped geographies, recent developments, and investments in the medical radiation shielding market
•Competitive Assessment: In-depth assessment of market shares, growth strategies, and service offerings of leading players, among others, in the medical radiation shielding market strategies.
Table of Contents

1INTRODUCTION24
1.1STUDY OBJECTIVES24
1.2MARKET DEFINITION24
1.2.1INCLUSIONS & EXCLUSIONS25
1.3MARKET SCOPE26
1.3.1MARKETS COVERED26
FIGURE 1MEDICAL RADIATION SHIELDING MARKET SEGMENTATION26
1.3.2GEOGRAPHIC SCOPE26
1.3.3YEARS CONSIDERED27
1.4CURRENCY27
1.5LIMITATIONS27
1.6MARKET STAKEHOLDERS28
1.7SUMMARY OF CHANGES28
2RESEARCH METHODOLOGY29
2.1RESEARCH DATA29
FIGURE 2RESEARCH DESIGN29
2.1.1SECONDARY DATA30
2.1.1.1Secondary sources30
2.1.2PRIMARY DATA31
FIGURE 3PRIMARY SOURCES31
2.1.2.1Key data from primary sources32
2.1.2.2Key industry insights33
2.1.2.3Breakdown of primary interviews33
FIGURE 4BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY- AND DEMAND-SIDE PARTICIPANTS33
FIGURE 5BREAKDOWN OF PRIMARY INTERVIEWS34
2.2MARKET SIZE ESTIMATION34
2.2.1GROWTH FORECAST36
FIGURE 6CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS36
FIGURE 7TOP-DOWN APPROACH37
2.3MARKET BREAKDOWN AND DATA TRIANGULATION38
FIGURE 8DATA TRIANGULATION METHODOLOGY38
2.4MARKET SHARE ANALYSIS39
2.5ASSUMPTIONS39
2.6INDICATORS AND ASSUMPTIONS40
2.7RISK ASSESSMENT40
TABLE 1RISK ASSESSMENT40
2.8IMPACT OF RECESSION: MEDICAL RADIATION SHIELDING MARKET41
3EXECUTIVE SUMMARY42
FIGURE 9MEDICAL RADIATION SHIELDING MARKET, BY PRODUCT, 2023 VS. 2028 (USD MILLION)42
FIGURE 10MEDICAL RADIATION SHIELDING MARKET, BY SOLUTION, 2023 VS. 2028 (USD MILLION)43
FIGURE 11MEDICAL RADIATION SHIELDING MARKET FOR RADIATION THERAPY SHIELDING, BY TYPE, 2023 VS. 2028 (USD MILLION)44
FIGURE 12MEDICAL RADIATION SHIELDING MARKET FOR DIAGNOSTIC SHIELDING, BY TYPE, 2023 VS. 2028 (USD MILLION)45
FIGURE 13MEDICAL RADIATION SHIELDING MARKET, BY END USER, 2023 VS. 2028 (USD MILLION)46
FIGURE 14GEOGRAPHICAL SNAPSHOT OF MEDICAL RADIATION SHIELDING MARKET47
4PREMIUM INSIGHTS48
4.1MEDICAL RADIATION SHIELDING MARKET OVERVIEW48
FIGURE 15GROWING GLOBAL INCIDENCE OF CANCER TO DRIVE MARKET GROWTH48
4.2NORTH AMERICA: MEDICAL RADIATION SHIELDING MARKET, BY SOLUTION AND COUNTRY, 202249
FIGURE 16DIAGNOSTIC SHIELDING HELD LARGEST SHARE OF NORTH AMERICAN MARKET IN 202249
4.3MEDICAL RADIATION SHIELDING MARKET: GEOGRAPHIC SNAPSHOT50
FIGURE 17CHINA TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD50
5MARKET OVERVIEW51
5.1INTRODUCTION51
5.2MARKET DYNAMICS51
FIGURE 18MEDICAL RADIATION SHIELDING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES51
5.2.1DRIVERS52
5.2.1.1Increasing use of nuclear medicine and radiation therapy for diagnosis and treatment52
5.2.1.2Growing incidence of cancer52
TABLE 2NUMBER OF NEW CANCER CASES, 2020–204053
TABLE 3INCREASING INCIDENCE OF CANCER, BY REGION, 2020 VS. 2030 VS. 2040 (MILLION)53
5.2.1.3Increasing safety awareness among people working in radiation-prone environments53
5.2.1.4Growth in number of PET/CT scans54
TABLE 4CT SCANNERS INSTALLED, BY COUNTRY, 2019 VS. 2021 (PER MILLION INHABITANTS)54
TABLE 5CT SCAN PROCEDURAL VOLUME, BY COUNTRY, 2019 VS. 2021 (PER 1,000 INHABITANTS)54
5.2.1.5Increasing number of trained radiologic technologists54
TABLE 6METROPOLITAN AREAS IN US WITH HIGH EMPLOYMENT LEVELS AMONG RADIOLOGY TECHNOLOGISTS AND TECHNICIANS55
5.2.2RESTRAINTS55
5.2.2.1Lack of adequate healthcare infrastructure55
5.2.2.2Shortage of skilled oncologists/radiologists55
5.2.3OPPORTUNITIES56
5.2.3.1Rising healthcare expenditure across developing countries56
5.2.3.2Increasing public-private investments in cancer research56
5.2.3.3Technological advancements in radiation detection57
5.2.4CHALLENGES57
5.2.4.1High cost of lead in manufacturing radiation accessories57
5.3VALUE CHAIN ANALYSIS58
FIGURE 19VALUE CHAIN ANALYSIS: MAJOR VALUE ADDED DURING MANUFACTURING AND ASSEMBLY PHASES58
5.4SUPPLY CHAIN ANALYSIS59
FIGURE 20DIRECT DISTRIBUTION—PREFERRED STRATEGY FOR PROMINENT COMPANIES59
5.5PORTER’S FIVE FORCES ANALYSIS60
5.5.1THREAT OF NEW ENTRANTS60
5.5.2THREAT OF SUBSTITUTES60
5.5.3BARGAINING POWER OF BUYERS60
5.5.4BARGAINING POWER OF SUPPLIERS60
5.5.5INTENSITY OF COMPETITIVE RIVALRY60
5.6KEY STAKEHOLDERS & BUYING CRITERIA61
5.6.1KEY STAKEHOLDERS IN BUYING PROCESS61
FIGURE 21INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR HOSPITALS, CLINICS, AND ASCS AND DIAGNOSTIC CENTERS61
TABLE 7INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP END USERS (%)61
5.6.2BUYING CRITERIA62
FIGURE 22KEY BUYING CRITERIA FOR HOSPITALS, CLINICS, AND ASCS AND DIAGNOSTIC CENTERS62
TABLE 8KEY BUYING CRITERIA FOR HOSPITALS, CLINICS, AND ASCS AND DIAGNOSTIC CENTERS62
5.7REGULATORY LANDSCAPE63
5.7.1NORTH AMERICA63
5.7.2EUROPE64
5.7.3ASIA PACIFIC64
5.8TRADE ANALYSIS64
TABLE 9IMPORT DATA FOR HS CODE 903010, BY COUNTRY, 2018–2022 (USD THOUSAND)64
TABLE 10EXPORT DATA FOR HS CODE 903010, BY COUNTRY, 2018–2022 (USD THOUSAND)65
5.9ECOSYSTEM ANALYSIS65
FIGURE 23KEY PLAYERS OPERATING IN MEDICAL RADIATION SHIELDING MARKET65
TABLE 11ROLE IN ECOSYSTEM66
5.10PATENT ANALYSIS67
5.11KEY CONFERENCES & EVENTS IN 2023–202468
TABLE 12LIST OF CONFERENCES & EVENTS68
5.12PRICING ANALYSIS69
5.12.1AVERAGE SELLING PRICE OF KEY PRODUCTS69
TABLE 13PRICE RANGE OF KEY PRODUCTS IN MEDICAL RADIATION SHIELDING MARKET (USD)69
5.13TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES70
5.14TECHNOLOGY ANALYSIS70
6MEDICAL RADIATION SHIELDING MARKET, BY PRODUCT72
6.1INTRODUCTION73
TABLE 14MEDICAL RADIATION SHIELDING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)73
6.2MRI SHIELDING PRODUCTS74
6.2.1INCREASING INSTALLATION BASE OF MRI SCANNERS WORLDWIDE TO BOOST MARKET74
TABLE 15MEDICAL RADIATION SHIELDING MARKET FOR MRI SHIELDING PRODUCTS, BY REGION, 2021–2028 (USD MILLION)74
6.3LEAD-LINED GLASS, DOORS, AND WINDOWS75
6.3.1ABILITY OF LEAD-LINED GLASS TO PROTECT PERSONNEL FROM UNNECESSARY RADIATION EXPOSURE TO PROPEL GROWTH75
TABLE 16MEDICAL RADIATION SHIELDING MARKET FOR LEAD-LINED GLASS, DOORS, AND WINDOWS, BY REGION, 2021–2028 (USD MILLION)75
6.4LEAD-LINED DRYWALLS & PLYWOOD76
6.4.1GROWING DEMAND FOR LEAD-LINED PLYWOOD FOR HEAVIER LEAD SHIELDING REQUIREMENTS TO BOOST MARKET76
TABLE 17MEDICAL RADIATION SHIELDING MARKET FOR LEAD-LINED DRYWALLS & PLYWOOD, BY REGION, 2021–2028 (USD MILLION)76
6.5SHIELDS, BARRIERS, AND BOOTHS77
6.5.1INCREASING NUMBER OF DIAGNOSTIC IMAGING CENTERS TO DRIVE GROWTH77
TABLE 18MEDICAL RADIATION SHIELDING MARKET FOR SHIELDS, BARRIERS, AND BOOTHS, BY REGION, 2021–2028 (USD MILLION)78
6.6LEAD SHEETS78
6.6.1CORROSION RESISTANCE ASSOCIATED WITH LEAD SHEETS TO FUEL DEMAND78
TABLE 19MEDICAL RADIATION SHIELDING MARKET FOR LEAD SHEETS, BY REGION, 2021–2028 (USD MILLION)79
6.7LEAD BRICKS79
6.7.1RESISTANCE TO DAMAGE TO DRIVE ADOPTION OF LEAD BRICKS79
TABLE 20MEDICAL RADIATION SHIELDING MARKET FOR LEAD BRICKS, BY REGION, 2021–2028 (USD MILLION)80
6.8HIGH-DENSITY CONCRETE BLOCKS80
6.8.1SIGNIFICANT ATTENUATION PROVIDED BY HIGH-DENSITY CONCRETE BLOCKS TO BOOST DEMAND80
TABLE 21MEDICAL RADIATION SHIELDING MARKET FOR HIGH-DENSITY CONCRETE BLOCKS, BY REGION, 2021–2028 (USD MILLION)81
6.9X-RAY ROOMS81
6.9.1DEVELOPMENT OF NEW MATERIALS AS ALTERNATIVES TO LEAD TO CREATE GROWTH OPPORTUNITIES81
TABLE 22MEDICAL RADIATION SHIELDING MARKET FOR X-RAY ROOMS, BY REGION, 2021–2028 (USD MILLION)82
6.10LEAD CURTAINS & SCREENS82
6.10.1GREATER SHIELDING CAPABILITY OF THICK LEAD SCREENS TO FAVOR MARKET GROWTH82
TABLE 23MEDICAL RADIATION SHIELDING MARKET FOR LEAD CURTAINS & SCREENS, BY REGION, 2021–2028 (USD MILLION)83
6.11LEAD ACRYLIC83
6.11.1SUPERIOR VISUAL CLARITY AND HIGH LIGHT TRANSMISSION OF LEAD ACRYLIC TO FUEL ADOPTION83
TABLE 24MEDICAL RADIATION SHIELDING MARKET FOR LEAD ACRYLIC, BY REGION, 2021–2028 (USD MILLION)84
7MEDICAL RADIATION SHIELDING MARKET, BY SOLUTION85
7.1INTRODUCTION86
TABLE 25MEDICAL RADIATION SHIELDING MARKET, BY SOLUTION, 2021–2028 (USD MILLION)86
7.2RADIATION THERAPY SHIELDING86
TABLE 26RADIATION THERAPY SHIELDING MARKET, BY REGION, 2021–2028 (USD MILLION)86
TABLE 27RADIATION THERAPY SHIELDING MARKET, BY TYPE, 2021–2028 (USD MILLION)87
7.2.1LINEAR ACCELERATORS87
7.2.1.1Growing adoption of linear accelerators to drive market growth87
TABLE 28MEDICAL RADIATION SHIELDING MARKET FOR LINEAR ACCELERATORS, BY REGION, 2021–2028 (USD MILLION)88
7.2.2MULTIMODALITY IMAGING88
7.2.2.1Recent advances in multimodality imaging to boost market88
TABLE 29MEDICAL RADIATION SHIELDING MARKET FOR MULTIMODALITY IMAGING, BY REGION, 2021–2028 (USD MILLION)88
7.2.3CYCLOTRONS89
7.2.3.1Ability of cyclotrons to produce high yields of short half-life, neutron-deficient radioisotopes to favor market growth89
TABLE 30MEDICAL RADIATION SHIELDING MARKET FOR CYCLOTRONS, BY REGION, 2021–2028 (USD MILLION)90
7.2.4BRACHYTHERAPY90
7.2.4.1Ability of brachytherapy to deliver low-dose radiation to drive market90
TABLE 31MEDICAL RADIATION SHIELDING MARKET FOR BRACHYTHERAPY, BY REGION, 2021–2028 (USD MILLION)91
7.2.5PROTON THERAPY91
7.2.5.1Non-invasive and non-threatening nature of proton therapy to fuel adoption91
TABLE 32MEDICAL RADIATION SHIELDING MARKET FOR PROTON THERAPY, BY REGION, 2021–2028 (USD MILLION)92
7.3DIAGNOSTIC SHIELDING92
TABLE 33DIAGNOSTIC SHIELDING MARKET, BY REGION, 2021–2028 (USD MILLION)92
TABLE 34DIAGNOSTIC SHIELDING MARKET, BY TYPE, 2021–2028 (USD MILLION)93
7.3.1CT SCANNERS93
7.3.1.1Rising demand for CT systems from hospitals, clinics, and ASCs to drive market93
TABLE 35MEDICAL RADIATION SHIELDING MARKET FOR CT SCANNERS, BY REGION, 2021–2028 (USD MILLION)94
7.3.2X-RAY IMAGING94
7.3.2.1Consistent high quality of images provided by digital imaging to boost demand94
TABLE 36MEDICAL RADIATION SHIELDING MARKET FOR X-RAY IMAGING, BY REGION, 2021–2028 (USD MILLION)95
7.3.3MRI95
7.3.3.1Wide use of MRI in hospitals for medical diagnosis and staging of diseases to boost growth95
TABLE 37MEDICAL RADIATION SHIELDING MARKET FOR MRI, BY REGION, 2021–2028 (USD MILLION)96
7.3.4NUCLEAR IMAGING96
7.3.4.1Recent advances in nuclear medicine to increase number of nuclear medicine procedures globally96
TABLE 38MEDICAL RADIATION SHIELDING MARKET FOR NUCLEAR MEDICINE, BY REGION, 2021–2028 (USD MILLION)97
8MEDICAL RADIATION SHIELDING MARKET, BY END USER98
8.1INTRODUCTION99
TABLE 39MEDICAL RADIATION SHIELDING MARKET, BY END USER, 2021–2028 (USD MILLION)99
8.2HOSPITALS, ASCS, AND CLINICS99
8.2.1INCREASING NUMBER OF INTERNAL RADIATION THERAPY PROCEDURES TO BOOST MARKET GROWTH99
TABLE 40MEDICAL RADIATION SHIELDING MARKET FOR HOSPITALS, ASCS, AND CLINICS, BY REGION, 2021–2028 (USD MILLION)100
8.3DIAGNOSTIC CENTERS100
8.3.1GROWING NUMBER OF DIAGNOSTIC CENTERS TO DRIVE GROWTH100
TABLE 41MEDICAL RADIATION SHIELDING MARKET FOR DIAGNOSTIC CENTERS, BY REGION, 2021–2028 (USD MILLION)101
9MEDICAL RADIATION SHIELDING MARKET, BY REGION102
9.1INTRODUCTION103
TABLE 42MEDICAL RADIATION SHIELDING MARKET, BY REGION, 2021–2028 (USD MILLION)103
9.2NORTH AMERICA103
9.2.1NORTH AMERICA: RECESSION IMPACT103
FIGURE 24NORTH AMERICA: MEDICAL RADIATION SHIELDING MARKET SNAPSHOT104
TABLE 43NORTH AMERICA: MEDICAL RADIATION SHIELDING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)104
TABLE 44NORTH AMERICA: MEDICAL RADIATION SHIELDING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)105
TABLE 45NORTH AMERICA: MEDICAL RADIATION SHIELDING MARKET, BY SOLUTION, 2021–2028 (USD MILLION)105
TABLE 46NORTH AMERICA: RADIATION THERAPY SHIELDING MARKET, BY TYPE, 2021–2028 (USD MILLION)106
TABLE 47NORTH AMERICA: DIAGNOSTIC SHIELDING MARKET, BY TYPE, 2021–2028 (USD MILLION)106
TABLE 48NORTH AMERICA: MEDICAL RADIATION SHIELDING MARKET, BY END USER, 2021–2028 (USD MILLION)106
9.2.2US107
9.2.2.1US to dominate North American medical radiation shielding market during forecast period107
TABLE 49US: MEDICAL RADIATION SHIELDING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)108
TABLE 50US: MEDICAL RADIATION SHIELDING MARKET, BY SOLUTION, 2021–2028 (USD MILLION)108
TABLE 51US: RADIATION THERAPY SHIELDING MARKET, BY TYPE, 2021–2028 (USD MILLION)109
TABLE 52US: DIAGNOSTIC SHIELDING MARKET, BY TYPE, 2021–2028 (USD MILLION)109
TABLE 53US: MEDICAL RADIATION SHIELDING MARKET, BY END USER, 2021–2028 (USD MILLION)109
9.2.3CANADA110
9.2.3.1Increasing number of radiography procedures to support market growth in Canada110
TABLE 54CANADA: MEDICAL RADIATION SHIELDING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)111
TABLE 55CANADA: MEDICAL RADIATION SHIELDING MARKET, BY SOLUTION, 2021–2028 (USD MILLION)111
TABLE 56CANADA: RADIATION THERAPY SHIELDING MARKET, BY TYPE, 2021–2028 (USD MILLION)112
TABLE 57CANADA: DIAGNOSTIC SHIELDING MARKET, BY TYPE, 2021–2028 (USD MILLION)112
TABLE 58CANADA: MEDICAL RADIATION SHIELDING MARKET, BY END USER, 2021–2028 (USD MILLION)112
9.3EUROPE113
9.3.1EUROPE: RECESSION IMPACT113
TABLE 59EUROPE: MEDICAL RADIATION SHIELDING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)114
TABLE 60EUROPE: MEDICAL RADIATION SHIELDING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)114
TABLE 61EUROPE: MEDICAL RADIATION SHIELDING MARKET, BY SOLUTION, 2021–2028 (USD MILLION)115
TABLE 62EUROPE: RADIATION THERAPY SHIELDING MARKET, BY TYPE, 2021–2028 (USD MILLION)115
TABLE 63EUROPE: DIAGNOSTIC SHIELDING MARKET, BY TYPE, 2021–2028 (USD MILLION)115
TABLE 64EUROPE: MEDICAL RADIATION SHIELDING MARKET, BY END USER, 2021–2028 (USD MILLION)116
9.3.2GERMANY116
9.3.2.1Growing geriatric population and increasing radiography procedures in Germany to favor market growth116
TABLE 65GERMANY: MEDICAL RADIATION SHIELDING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)117
TABLE 66GERMANY: MEDICAL RADIATION SHIELDING MARKET, BY SOLUTION, 2021–2028 (USD MILLION)117
TABLE 67GERMANY: RADIATION THERAPY SHIELDING MARKET, BY TYPE, 2021–2028 (USD MILLION)118
TABLE 68GERMANY: DIAGNOSTIC SHIELDING MARKET, BY TYPE, 2021–2028 (USD MILLION)118
TABLE 69GERMANY: MEDICAL RADIATION SHIELDING MARKET, BY END USER, 2021–2028 (USD MILLION)118
9.3.3FRANCE119
9.3.3.1Large number of CT procedures performed to fuel market119
TABLE 70FRANCE: MEDICAL RADIATION SHIELDING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)119
TABLE 71FRANCE: MEDICAL RADIATION SHIELDING MARKET, BY SOLUTION, 2021–2028 (USD MILLION)120
TABLE 72FRANCE: RADIATION THERAPY SHIELDING MARKET, BY TYPE, 2021–2028 (USD MILLION)120
TABLE 73FRANCE: DIAGNOSTIC SHIELDING MARKET, BY TYPE, 2021–2028 (USD MILLION)120
TABLE 74FRANCE: MEDICAL RADIATION SHIELDING MARKET, BY END USER, 2021–2028 (USD MILLION)121
9.3.4UK121
9.3.4.1Increasing government initiatives and support to aid market121
TABLE 75UK: MEDICAL RADIATION SHIELDING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)122
TABLE 76UK: MEDICAL RADIATION SHIELDING MARKET, BY SOLUTION, 2021–2028 (USD MILLION)122
TABLE 77UK: RADIATION THERAPY SHIELDING MARKET, BY TYPE, 2021–2028 (USD MILLION)123
TABLE 78UK: DIAGNOSTIC SHIELDING MARKET, BY TYPE, 2021–2028 (USD MILLION)123
TABLE 79UK: MEDICAL RADIATION SHIELDING MARKET, BY END USER, 2021–2028 (USD MILLION)123
9.3.5REST OF EUROPE124
TABLE 80REST OF EUROPE: MEDICAL RADIATION SHIELDING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)124
TABLE 81REST OF EUROPE: MEDICAL RADIATION SHIELDING MARKET, BY SOLUTION, 2021–2028 (USD MILLION)124
TABLE 82REST OF EUROPE: RADIATION THERAPY SHIELDING MARKET, BY TYPE, 2021–2028 (USD MILLION)125
TABLE 83REST OF EUROPE: DIAGNOSTIC SHIELDING MARKET, BY TYPE, 2021–2028 (USD MILLION)125
TABLE 84REST OF EUROPE: MEDICAL RADIATION SHIELDING MARKET, BY END USER, 2021–2028 (USD MILLION)125
9.4ASIA PACIFIC126
9.4.1ASIA PACIFIC: RECESSION IMPACT126
FIGURE 25ASIA PACIFIC: MEDICAL RADIATION SHIELDING MARKET SNAPSHOT127
TABLE 85ASIA PACIFIC: MEDICAL RADIATION SHIELDING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)128
TABLE 86ASIA PACIFIC: MEDICAL RADIATION SHIELDING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)128
TABLE 87ASIA PACIFIC: MEDICAL RADIATION SHIELDING MARKET, BY SOLUTION, 2021–2028 (USD MILLION)129
TABLE 88ASIA PACIFIC: RADIATION THERAPY SHIELDING MARKET, BY TYPE, 2021–2028 (USD MILLION)129
TABLE 89ASIA PACIFIC: DIAGNOSTIC SHIELDING MARKET, BY TYPE, 2021–2028 (USD MILLION)129
TABLE 90ASIA PACIFIC: MEDICAL RADIATION SHIELDING MARKET, BY END USER, 2021–2028 (USD MILLION)130
9.4.2CHINA130
9.4.2.1Large patient pool and rising healthcare spending to aid market130
TABLE 91CHINA: MEDICAL RADIATION SHIELDING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)131
TABLE 92CHINA: MEDICAL RADIATION SHIELDING MARKET, BY SOLUTION, 2021–2028 (USD MILLION)131
TABLE 93CHINA: RADIATION THERAPY SHIELDING MARKET, BY TYPE, 2021–2028 (USD MILLION)132
TABLE 94CHINA: DIAGNOSTIC SHIELDING MARKET, BY TYPE, 2021–2028 (USD MILLION)132
TABLE 95CHINA: MEDICAL RADIATION SHIELDING MARKET, BY END USER, 2021–2028 (USD MILLION)132
9.4.3JAPAN133
9.4.3.1Rising awareness about radiation exposure to drive market133
TABLE 96JAPAN: MEDICAL RADIATION SHIELDING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)133
TABLE 97JAPAN: MEDICAL RADIATION SHIELDING MARKET, BY SOLUTION, 2021–2028 (USD MILLION)134
TABLE 98JAPAN: RADIATION THERAPY SHIELDING MARKET, BY TYPE, 2021–2028 (USD MILLION)134
TABLE 99JAPAN: DIAGNOSTIC SHIELDING MARKET, BY TYPE, 2021–2028 (USD MILLION)134
TABLE 100JAPAN: MEDICAL RADIATION SHIELDING MARKET, BY END USER, 2021–2028 (USD MILLION)135
9.4.4INDIA135
9.4.4.1Favorable government policies and healthcare infrastructure to support market135
TABLE 101INDIA: MEDICAL RADIATION SHIELDING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)136
TABLE 102INDIA: MEDICAL RADIATION SHIELDING MARKET, BY SOLUTION, 2021–2028 (USD MILLION)136
TABLE 103INDIA: RADIATION THERAPY SHIELDING MARKET, BY TYPE, 2021–2028 (USD MILLION)137
TABLE 104INDIA: DIAGNOSTIC SHIELDING MARKET, BY TYPE, 2021–2028 (USD MILLION)137
TABLE 105INDIA: MEDICAL RADIATION SHIELDING MARKET, BY END USER, 2021–2028 (USD MILLION)137
9.4.5REST OF ASIA PACIFIC138
TABLE 106INCIDENCE OF CANCER IN REST OF ASIA PACIFIC, 2020 VS. 2040138
TABLE 107REST OF ASIA PACIFIC: MEDICAL RADIATION SHIELDING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)139
TABLE 108REST OF ASIA PACIFIC: MEDICAL RADIATION SHIELDING MARKET, BY SOLUTION, 2021–2028 (USD MILLION)139
TABLE 109REST OF ASIA PACIFIC: RADIATION THERAPY SHIELDING MARKET, BY TYPE, 2021–2028 (USD MILLION)140
TABLE 110REST OF ASIA PACIFIC: DIAGNOSTIC SHIELDING MARKET, BY TYPE, 2021–2028 (USD MILLION)140
TABLE 111REST OF ASIA PACIFIC: MEDICAL RADIATION SHIELDING MARKET, BY END USER, 2021–2028 (USD MILLION)140
9.5REST OF THE WORLD (ROW)141
9.5.1REST OF THE WORLD (ROW): RECESSION IMPACT141
TABLE 112REST OF THE WORLD: MEDICAL RADIATION SHIELDING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)142
TABLE 113REST OF THE WORLD: MEDICAL RADIATION SHIELDING MARKET, BY SOLUTION, 2021–2028 (USD MILLION)143
TABLE 114REST OF THE WORLD: RADIATION THERAPY SHIELDING MARKET, BY TYPE, 2021–2028 (USD MILLION)143
TABLE 115REST OF THE WORLD: DIAGNOSTIC SHIELDING MARKET, BY TYPE, 2021–2028 (USD MILLION)143
TABLE 116REST OF THE WORLD: MEDICAL RADIATION SHIELDING MARKET, BY END USER, 2021–2028 (USD MILLION)144
10COMPETITIVE LANDSCAPE145
10.1OVERVIEW145
TABLE 117OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN MEDICAL RADIATION SHIELDING MARKET145
10.2MARKET RANKING146
TABLE 118TOP 3 COMPANIES IN MEDICAL RADIATION SHIELDING MARKET146
10.3COMPANY EVALUATION QUADRANT FOR TOP PLAYERS146
10.3.1STARS147
10.3.2EMERGING LEADERS147
10.3.3PARTICIPANTS147
10.3.4PERVASIVE PLAYERS147
FIGURE 26MEDICAL RADIATION SHIELDING MARKET: COMPANY EVALUATION QUADRANT FOR KEY PLAYERS, 2022148
10.4COMPANY EVALUATION QUADRANT FOR SMES/STARTUPS149
10.4.1PROGRESSIVE COMPANIES149
10.4.2STARTING BLOCKS149
10.4.3RESPONSIVE COMPANIES149
10.4.4DYNAMIC COMPANIES149
FIGURE 27MEDICAL RADIATION SHIELDING MARKET: COMPANY EVALUATION MATRIX FOR SMES/STARTUPS, 2022150
10.5COMPETITIVE BENCHMARKING151
TABLE 119MEDICAL RADIATION SHIELDING MARKET: DETAILED LIST OF KEY STARTUPS/SMES151
10.6COMPANY FOOTPRINT ANALYSIS151
TABLE 120FOOTPRINT ANALYSIS OF COMPANIES151
TABLE 121REGIONAL FOOTPRINT ANALYSIS OF COMPANIES152
TABLE 122PRODUCT FOOTPRINT ANALYSIS OF COMPANIES153
10.7COMPETITIVE SCENARIO154
10.7.1DEALS154
TABLE 123KEY DEALS, JANUARY 2020–MAY 2023154
10.7.2OTHER DEVELOPMENTS155
TABLE 124OTHER KEY DEVELOPMENTS, JANUARY 2020–MAY 2023155
11COMPANY PROFILES156
11.1KEY PLAYERS156
(Business overview, Products offered, Recent Developments, MNM view)*
11.1.1ETS-LINDGREN (AN ESCO TECHNOLOGIES COMPANY)156
TABLE 125ETS-LINDGREN (AN ESCO TECHNOLOGIES COMPANY): BUSINESS OVERVIEW156
FIGURE 28ETS-LINDGREN (AN ESCO TECHNOLOGIES COMPANY): COMPANY SNAPSHOT (2022)157
11.1.2BIODEX (A PART OF MIRION TECHNOLOGIES, INC.)161
TABLE 126BIODEX (A PART OF MIRION TECHNOLOGIES, INC.): BUSINESS OVERVIEW161
FIGURE 29BIODEX (A PART OF MIRION TECHNOLOGIES, INC.): COMPANY SNAPSHOT (2022)162
11.1.3NELCO WORLDWIDE165
TABLE 127NELCO WORLDWIDE: BUSINESS OVERVIEW165
11.1.4GAVEN INDUSTRIES, INC.167
TABLE 128GAVEN INDUSTRIES, INC.: BUSINESS OVERVIEW167
11.1.5RADIATION PROTECTION PRODUCTS, INC.168
TABLE 129RADIATION PROTECTION PRODUCTS, INC.: BUSINESS OVERVIEW168
11.1.6MARSHIELD (A DIVISION OF MARS METAL CO.)170
TABLE 130MARSHIELD (A DIVISION OF MARS METAL CO.): BUSINESS OVERVIEW170
11.1.7RAY-BAR ENGINEERING CORP.172
TABLE 131RAY-BAR ENGINEERING CORP.: BUSINESS OVERVIEW172
11.1.8AMRAY MEDICAL174
TABLE 132AMRAY MEDICAL: BUSINESS OVERVIEW174
11.1.9A&L SHIELDING175
TABLE 133A&L SHIELDING: BUSINESS OVERVIEW175
11.1.10GLOBAL PARTNERS IN SHIELDING, INC.177
TABLE 134GLOBAL PARTNERS IN SHIELDING, INC.: BUSINESS OVERVIEW177
11.1.11VERITAS MEDICAL SOLUTIONS LLC178
TABLE 135VERITAS MEDICAL SOLUTIONS, LLC: BUSINESS OVERVIEW178
11.1.12ALIMED, INC.179
TABLE 136ALIMED, INC.: BUSINESS OVERVIEW179
11.1.13PROTECH MEDICAL180
TABLE 137PROTECH MEDICAL: BUSINESS OVERVIEW180
11.1.14GLOBE COMPOSITE SOLUTIONS LLC181
TABLE 138GLOBE COMPOSITE SOLUTIONS LLC: BUSINESS OVERVIEW181
11.1.15ULTRARAY182
TABLE 139ULTRARAY: BUSINESS OVERVIEW182
11.1.16MARS METAL COMPANY183
TABLE 140MARS METAL COMPANY: BUSINESS OVERVIEW183
11.1.17NUCLEAR LEAD CO.185
TABLE 141NUCLEAR LEAD CO.: BUSINESS OVERVIEW185
11.1.18NUCLEAR SHIELDS B.V.186
TABLE 142NUCLEAR SHIELDS B.V.: BUSINESS OVERVIEW186
*Details on Business overview, Products offered, Recent Developments, MNM view might not be captured in case of unlisted companies.
11.2OTHER PLAYERS188
11.2.1SHIELDING INTERNATIONAL INC.188
11.2.2BAR-RAY PRODUCTS, INC.188
11.2.3XENA SHIELD189
11.2.4BURLINGTON MEDICAL190
11.2.5SIMAD SRL190
11.2.6EUROPEAN EMC PRODUCTS191
12APPENDIX192
12.1DISCUSSION GUIDE192
12.2KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL197
12.3CUSTOMIZATION OPTIONS199
12.4RELATED REPORTS199
12.5AUTHOR DETAILS200

Report Title: Medical Radiation Shielding Market by Products (Shields, Booths, Lead sheet, Doors, Windows, Curtain, X-Ray), Solution (Radiation Therapy, Cyclotron, PET, CT, MRI), End-user (Hospitals, Clinics, ASCs, Diagnostic Center), & Region - Global Forecast to 2028


Your Details
Valid Invalid number

SELECT A FORMAT

ADD TO CART BUY NOW

Related Report

US Bispecific Antibodies  Market & Clinical Pipeline Insight 2028

US Bispecific Antibodies Market & Clinical Pipeline Insight 2028

2023-2027 Vietnam Molecular Blood Typing, Grouping and Infectious Disease NAT Screening  Analyzers and Reagents--Transfusion Market Emerging Opportunities, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 40 Immunohematology and NAT Assays through 2027, Latest Technologies and Instrumentation Pipeline

2023-2027 Vietnam Molecular Blood Typing, Grouping and Infectious Disease NAT Screening Analyzers and Reagents--Transfusion Market Emerging Opportunities, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 40 Immunohematology and NAT Assays through 2027, Latest Technologies and Instrumentation Pipeline

2023-2027 Venezuela Molecular Blood Typing, Grouping and Infectious Disease NAT Screening  Analyzers and Reagents--Transfusion Market Emerging Opportunities, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 40 Immunohematology and NAT Assays through 2027, Latest Technologies and Instrumentation Pipeline

2023-2027 Venezuela Molecular Blood Typing, Grouping and Infectious Disease NAT Screening Analyzers and Reagents--Transfusion Market Emerging Opportunities, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 40 Immunohematology and NAT Assays through 2027, Latest Technologies and Instrumentation Pipeline

2023-2027 Uruguay Molecular Blood Typing, Grouping and Infectious Disease NAT Screening  Analyzers and Reagents--Transfusion Market Emerging Opportunities, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 40 Immunohematology and NAT Assays through 2027, Latest Technologies and Instrumentation Pipeline

2023-2027 Uruguay Molecular Blood Typing, Grouping and Infectious Disease NAT Screening Analyzers and Reagents--Transfusion Market Emerging Opportunities, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 40 Immunohematology and NAT Assays through 2027, Latest Technologies and Instrumentation Pipeline

2023-2027 United Arab Emirates Molecular Blood Typing, Grouping and Infectious Disease NAT Screening  Analyzers and Reagents--Transfusion Market Emerging Opportunities, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 40 Immunohematology and NAT Assays through 2027, Latest Technologies and Instrumentation Pipeline

2023-2027 United Arab Emirates Molecular Blood Typing, Grouping and Infectious Disease NAT Screening Analyzers and Reagents--Transfusion Market Emerging Opportunities, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 40 Immunohematology and NAT Assays through 2027, Latest Technologies and Instrumentation Pipeline

2023-2027 Ukraine Molecular Blood Typing, Grouping and Infectious Disease NAT Screening  Analyzers and Reagents--Transfusion Market Emerging Opportunities, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 40 Immunohematology and NAT Assays through 2027, Latest Technologies and Instrumentation Pipeline

2023-2027 Ukraine Molecular Blood Typing, Grouping and Infectious Disease NAT Screening Analyzers and Reagents--Transfusion Market Emerging Opportunities, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 40 Immunohematology and NAT Assays through 2027, Latest Technologies and Instrumentation Pipeline